Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Claus Bossaller"'
Autor:
Rudolf Schiele, Claus Juenger, Jochen Senges, Claus Bossaller, Harm Wienbergen, Peter Limbourg, Christina Meisenzahl, Anselm K. Gitt, Tobias Heer
Publikováno v:
The American Journal of Cardiology. 92:285-288
In clinical practice, we found no significant difference between atorvastatin therapy or other statin therapies in the clinical outcomes of patients with acute coronary syndromes receiving clopidogrel therapy. In patients receiving atorvastatin thera
Autor:
Tobias Heer, Christina Meisenzahl, Claus Juenger, Anselm K. Gitt, Jochen Senges, Harm Wienbergen, Helmut Landgraf, Rudolf Schiele, Claus Bossaller
Publikováno v:
The American Journal of Cardiology. 90:1045-1049
We examined the impact of treatment with ramipril versus other angiotensin-converting enzyme (ACE) inhibitors on clinical outcome in unselected patients of the prospective multicenter registry Maximal Individual Therapy of Acute Myocardial Infarction
Autor:
Jochen Senges, Karlheinz Seidl, Gerhard Schuler, Ralf Zahn, Werner Rosahl, Anselm K. Gitt, Ernst Altmann, Claus Bossaller, Rudolf Schiele, Steffen Schneider, Martin Gottwik
Publikováno v:
The American Journal of Cardiology. 87:1-6
Preinfarction angina is associated with better clinical outcome in patients with acute myocardial infarction (AMI) who receive intravenous thrombolysis. This has not been proved in patients with AMI treated with primary angioplasty. We analyzed the d
Autor:
Claus Bossaller, Rudolf Schiele, Anselm K. Gitt, Martin Gottwik, Jochen Senges, Heinz Joachim Büttner, Karlheinz Seidl, Ernst Altmann, Steffen Schneider, Harm Wienbergen, Ralf Zahn, Werner Rosahl
Publikováno v:
Journal of the American College of Cardiology. 36:2064-2071
OBJECTIVES We investigated changes in the clinical outcome of primary angioplasty and thrombolysis for the treatment of acute myocardial infarction (AMI) from 1994 to 1998. BACKGROUND Primary angioplasty for the treatment of AMI is a sophisticated te
Autor:
Claus Bossaller, Eckart Fleck, Wolfgang Auch-Schwelk, Michael Gräfe, Kristof Graf, Frauke Weber, Stephan Götze
Publikováno v:
Journal of Cardiovascular Pharmacology. 20:91-95
The study was designed to evaluate the effects of chronic inhibition of angiotensin-converting enzyme (ACE) on the reactivity of the endothelium and the smooth muscle to vasoconstrictor and vasodilator stimuli in normal rats. Male rats were treated o
Autor:
Matthias Claus, Michael Gräfe, Eckart Fleck, Kristof Graf, Claus Bossaller, Wolfgang Auch-Schwelk
Publikováno v:
Journal of Cardiovascular Pharmacology. 20:62-67
The interaction of angiotensin-converting enzyme (ACE) inhibitors and bradykinin was investigated in isolated bovine and human coronary arteries. Rings with and without endothelium were mounted in organ chambers for measurement of isometric force. Th
Publikováno v:
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies. 31(5)
The presence of neutral endopeptidase 24.11 was demonstrated in human umbilical vein endothelial cells by immunostaining. Enzymatic activity of neutral endopeptidase was determined as 0.167 +/- 0.02 mU/mg protein in the membrane fraction of human umb
Publikováno v:
Journal of cardiovascular pharmacology. 21(3)
We wished to characterize the altered reactivity of vascular smooth muscle and endothelial cells in rat aorta during chronic treatment with cyclosporin. Male adult rats were treated orally for 6 weeks with either cyclosporin A (30 mg/kg/day in 1 ml o
Autor:
Michael Gräfe, Eckart Fleck, Wolfgang Auch-Schwelk, Matthias Claus, Claus Bossaller, Kristof Graf
Publikováno v:
Cardiovascular research. 27(2)
Objective: The effect of angiotensin converting enzyme (ACE) inhibitors on vascular tone of isolated coronary arteries was determined in the presence of bradykinin and other vasodilators to elucidate the mechanisms leading to augmented bradykinin eff
Autor:
Kristof Graf, Claus R. Baumgarten, Eckart Fleck, Wolfgang Auch-Schwelk, Claus Bossaller, Michael Gräfe
Publikováno v:
Journal of cardiovascular pharmacology. 20
The role of angiotensin-converting enzyme (ACE), neutral endopeptidase 24.11 (NEP), and other peptidases in the endothelial degradation of bradykinin was investigated in cultured human umbilical vein endothelial cells (HUVEC). The major part of the k